-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on CervoMed, Maintains $31 Price Target

Benzinga·02/18/2026 12:38:11
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains CervoMed (NASDAQ:CRVO) with a Buy and maintains $31 price target.